Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Actinic Keratosis Market Expected To Grow In Terms Of Size?

The market for actinic keratosis has been on a steady rise in the years past. It’s set to expand from $7.95 billion in 2024 to $8.42 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. Several factors contribute to this growth during the historic period. These include heightened exposure to UV radiation, an aging population, increased knowledge about skin cancer, a growing number of actinic keratosis cases, an expanding healthcare sector, higher disposable income levels, supportive government initiatives, and an increasing emphasis on preventive skincare.

The market for actinic keratosis is projected to experience substantial growth in the upcoming years, escalating to a $10.5 billion valuation in 2029, reflecting a compound annual growth rate (CAGR) of 5.7%. Several factors contribute to this expansion during the forecasted period which include innovative therapeutic introductions, improvements in AI-driven diagnostic devices, the increasing preference for combination therapies, the surge in demand for non-invasive procedures and the expansion of tele dermatology. Other factors include the growing utilization of photodynamic treatment, heightened consciousness about aesthetic outcomes, the arrival of specialized biological treatments, ballooning healthcare investment in emerging markets and heightened emphasis on preventative care and early detection. Key trends during the forecasted period consist of AI-powered diagnostic tools, the use of machine learning in lesion analysis, state-of-the-art photodynamic therapy systems, wearable devices for UV radiation monitoring, nanotechnology utilized in drug delivery, 3D imaging for tailored treatments, user-friendly home-based phototherapy devices, biosensors for early detection, software for automated lesion classification, and therapeutic systems based on hydrogel.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Which Key Factors Are Fueling Growth In The Actinic Keratosis Market?

The surge in severe sunburn cases is poised to fuel the expansion of the actinic keratosis market in the near future. Severe sunburns, intense skin injuries resulting from excess exposure to UV radiation, cause symptoms like redness, pain, swelling, and sometimes even blistering. Factors such as extended exposure to UV radiation, inadequate sun protection, heightened outdoor activities during peak UV times and increasing temperatures due to global warming contribute to sunburns. Sunburns lead to actinic keratosis by harming the DNA of skin cells via UV radiation, causing mutations that interfere with normal cell operation and giving rise to precancerous lesions, particularly with repeated or extended exposure to the sun. For example, Melanoma Focus, a UK charity, reported in May 2024 that in the year 2022-23, there were 201 hospital admissions due to sunburn, including 89 children and 25 infants under one year old. The charity also discovered that 66% of UK adults between the ages of 16-65 recalled being sunburned as children, and 65% had suffered a severe sunburn with at least one instance of blistering. This figure increased to 77% for individuals with light, pale or white skin. Consequently, the rising instances of severe sunburns are stimulating the growth of the actinic keratosis market.

How Is The Actinic Keratosis Market Categorized Across Applications And Types?

The actinic keratosismarket covered in this report is segmented –

1) By Treatment Type: Topical Treatment; Surgical Procedure; Photodynamic Therapy; Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers

3) By End-User: Hospitals; Dermatology Clinics; Spas And Rejuvenation Centers; Homecare Settings; Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU); Imiquimod; Diclofenac; Ingenol Mebutate; Retinoids

2) By Surgical Procedure: Cryotherapy; Curettage And Electrodessication; Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy; Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy; Chemical Peels; Combination Therapies

How Are Industry Trends Steering The Expansion Of The Actinic Keratosis Market?

Prominent businesses in the actinic keratosis market are focusing on the creation of topical ointments aimed at effectively addressing and eradicating precancerous lesions while reducing recurrence percentages and improving patient adherence with shorter treatment periods and better safety measures. Active ingredients such as tirbanibulin are incorporated in these topical ointments, which are therapeutic creams or gels directly placed on the affected skin; these target abnormal keratinocytes to address precancerous lesions. For instance, Almirall SA, a biopharmaceutical firm based in Spain, gained approval from the US Food and Drug Administration (FDA) in June 2024 for a supplemental new drug application (sNDA) to increase the usage area of its drug, Klisyri, to as much as 100 cm2. Klisyri (tirbanibulin) 1% ointment, a microtubule inhibitor, is engineered to halt the growth of abnormal keratinocytes, thus significantly diminishing the count and magnitude of precancerous lesions in the treatment of actinic keratosis (AK) on the face or scalp.

Which Firms Are Making The Biggest Impact In The Actinic Keratosis Market?

Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Region Holds The Greatest Opportunity For Actinic Keratosis Market Expansion?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Browse Through More Reports Similar to the Global Actinic Keratosis Market 2025, By The Business Research Company

Actinic Keratosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-treatment-global-market-report

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model